Ro Khanna @RoKhanna
The Inflation Reduction Act capped the cost of insulin at $35 per month for Medicare patients. Now Eli Lilly is extending that price to all their customers. More pharmaceutical companies should take note and do their part to lower the cost of vital medication. — PolitiTweet.org